What does Biofund IV invest in?

Biofund IV invests in Biotech at the seed and series-a stages.

Which geographies does Biofund IV focus on?

Biofund IV focuses on Europe, and is headquartered in France.

Open Biofund IV in the live Raise dashboard →

Biofund IV

Kurma Partners

Kurma Biofund IV is a €215 million venture capital fund managed by Kurma Partners, dedicated to investing in innovative therapeutics addressing diseases with high medical needs, primarily in life sciences and biotechnology. It focuses 80% of investments on therapeutic approaches, including company creations and venture-stage companies, with up to 50% allocated to firms established by Kurma or Argobio. The fund targets 16-20 investments across Europe and beyond, leveraging academic science and industry networks.

Biofund IV (Kurma Partners) invests at seed and Series A, focuses on Biotech, backs founders in Europe.

Stages

seedSeries A

Sectors

Biotech

Geographies

Europe

Headquarters

France

Visit website

🔒 Team & partners

🔒 Live funding signals

🔒 Contacts

Team & partners, portfolio, live funding signals and contacts. Free account, Google sign-in.

Create free account

Verified 2 June 2026 · Sources: company website, Fusion42 review

Frequently asked questions

What does Biofund IV invest in?: Biofund IV invests in Biotech at the seed and series-a stages.
Which geographies does Biofund IV focus on?: Biofund IV focuses on Europe, and is headquartered in France.